198 related articles for article (PubMed ID: 35906381)
1. Association of hormone replacement therapy with risk of gastric cancer: a systematic review and meta-analysis.
Jang YC; Leung CY; Huang HL
Sci Rep; 2022 Jul; 12(1):12997. PubMed ID: 35906381
[TBL] [Abstract][Full Text] [Related]
2. Association of hormone replacement therapy with mortality in colorectal cancer survivor: a systematic review and meta-analysis.
Jang YC; Huang HL; Leung CY
BMC Cancer; 2019 Dec; 19(1):1199. PubMed ID: 31818262
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
4. The association between different hormone replacement therapy use and the incidence of lung cancer: a systematic review and meta-analysis.
Wen H; Lin X; Sun D
J Thorac Dis; 2022 Feb; 14(2):381-395. PubMed ID: 35280481
[TBL] [Abstract][Full Text] [Related]
5. Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis.
Li D; Ding CY; Qiu LH
Gynecol Oncol; 2015 Nov; 139(2):355-62. PubMed ID: 26232517
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy after surgery for epithelial ovarian cancer.
Saeaib N; Peeyananjarassri K; Liabsuetrakul T; Buhachat R; Myriokefalitaki E
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012559. PubMed ID: 31989588
[TBL] [Abstract][Full Text] [Related]
7. The oncologic impact of hormone replacement therapy in premenopausal breast cancer survivors: A systematic review.
Wang Y; Lewin N; Qaoud Y; Rajaee AN; Scheer AS
Breast; 2018 Aug; 40():123-130. PubMed ID: 29763858
[TBL] [Abstract][Full Text] [Related]
8. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.
Anagnostis P; Galanis P; Chatzistergiou V; Stevenson JC; Godsland IF; Lambrinoudaki I; Theodorou M; Goulis DG
Maturitas; 2017 May; 99():27-36. PubMed ID: 28364865
[TBL] [Abstract][Full Text] [Related]
9. Impact of hormone replacement therapy on all-cause and cancer-specific mortality in colorectal cancer: A systematic review and dose‒response meta-analysis of observational studies.
Liu K; He Y; Li Q; Sun S; Mei Z; Zhao J
J Evid Based Med; 2024 Jun; 17(2):377-389. PubMed ID: 38943605
[TBL] [Abstract][Full Text] [Related]
10. Association of Menopausal Hormone Therapy with Risk of Pancreatic Cancer: A Systematic Review and Meta-analysis of Cohort Studies.
Jang YC; Leung CY; Huang HL
Cancer Epidemiol Biomarkers Prev; 2023 Jan; 32(1):114-122. PubMed ID: 36306390
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Fundamental Frequency in Postmenopausal Women Who Are Treated With Hormone Replacement Therapy vs Those Who Are Not: A Systematic Review and Meta-analysis.
Lin RJ; Wang T
JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1045-1053. PubMed ID: 32790826
[TBL] [Abstract][Full Text] [Related]
12. Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis.
Camargo MC; Goto Y; Zabaleta J; Morgan DR; Correa P; Rabkin CS
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):20-38. PubMed ID: 22028402
[TBL] [Abstract][Full Text] [Related]
13. The Relationship Between Hormone Replacement Therapy and Risk of Kidney Cancer in Women: A Meta-Analysis.
Zhang X; Du Y; Tan X; Wang H; Li Y; Zhang Z; Wang A
Cancer Control; 2020; 27(2):1073274820930194. PubMed ID: 32668959
[TBL] [Abstract][Full Text] [Related]
14. Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis.
Poggio F; Del Mastro L; Bruzzone M; Ceppi M; Razeti MG; Fregatti P; Ruelle T; Pronzato P; Massarotti C; Franzoi MA; Lambertini M; Tagliamento M
Breast Cancer Res Treat; 2022 Jan; 191(2):269-275. PubMed ID: 34731351
[TBL] [Abstract][Full Text] [Related]
15. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
Norman RJ; Flight IH; Rees MC
Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
[TBL] [Abstract][Full Text] [Related]
16. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
[TBL] [Abstract][Full Text] [Related]
17. Is the oral contraceptive or hormone replacement therapy a risk factor for cholelithiasis: A systematic review and meta-analysis.
Wang S; Wang Y; Xu J; Chen Y
Medicine (Baltimore); 2017 Apr; 96(14):e6556. PubMed ID: 28383429
[TBL] [Abstract][Full Text] [Related]
18. Menopausal hormone therapy and women's health: An umbrella review.
Zhang GQ; Chen JL; Luo Y; Mathur MB; Anagnostis P; Nurmatov U; Talibov M; Zhang J; Hawrylowicz CM; Lumsden MA; Critchley H; Sheikh A; Lundbäck B; Lässer C; Kankaanranta H; Lee SH; Nwaru BI
PLoS Med; 2021 Aug; 18(8):e1003731. PubMed ID: 34339416
[TBL] [Abstract][Full Text] [Related]
19. Menopausal hormone therapy and the risk of breast cancer by histological type and race: a meta-analysis of randomized controlled trials and cohort studies.
Kim S; Ko Y; Lee HJ; Lim JE
Breast Cancer Res Treat; 2018 Aug; 170(3):667-675. PubMed ID: 29713854
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy and mammographic density: a systematic literature review.
Azam S; Jacobsen KK; Aro AR; Lynge E; Andersen ZJ
Breast Cancer Res Treat; 2020 Aug; 182(3):555-579. PubMed ID: 32572713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
